Changes in QoL and Symptoms in Patients With Polycythemia Vera Receiving Ruxo in a Routine Clinical Practice
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Ruxolitinib
Related studies linked through entity extraction aliases.
Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis
- Status
- RECRUITING
- Phase
- PHASE4
A New Prognostic Stratification-based Safety and Efficacy Study of Ruxolitinib in Myelofibrosis
- Status
- UNKNOWN
- Phase
- PHASE4
Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Ruxolitinib in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- N/A
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE1
Topical Ruxolitinib in Chronic Hand Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Ruxolitinib and Methylprednisolone as a First-line Treatment for Macrophage Activation Syndrome
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- PHASE1
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
ECP Combination Study
- Status
- COMPLETED
- Phase
- N/A
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE2
Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD
- Status
- UNKNOWN
- Phase
- PHASE4
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)
- Status
- TERMINATED
- Phase
- PHASE3